Novartis completes acquisition of 25% stake in Alcon from Nestlé
- Details
- Category: Novartis

Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
- Details
- Category: Pfizer

Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
- Details
- Category: Novartis

Shire proposes acquisition of Jerini AG for an equity purchase price of €328 million
- Details
- Category: Shire

Summary Judgment Granted for SEROQUEL Patent Litigation in the US
- Details
- Category: AstraZeneca

GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
- Details
- Category: GlaxoSmithKline

Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development
- Details
- Category: Novartis

More Pharma News ...
- Roche's tender offer to increase ownership stake in Chugai successful
- Abbott and Partnership for a Drug-Free America Launch 'Not In My House'
- Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United Stat
- Cervarixâ¢, GSK's cervical cancer vaccine, wins tender for UK national immunisation programme
- Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
- Genzyme Files Applications for Approval of Mozobil in the United States and Europe
- AstraZeneca and Columbia University Medical Center Sign Strategic Research Collaboration